CTSH vs EBS · P/E 12, rev $19.74B vs rev $1.04B
Cognizant Technology Solutions Corp Class A (CTSH) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Cognizant Technology Solutions Corp Class A (CTSH) is a information technology services company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CTSH revenue for 2024-12-31 was $19.74B. Net income was $2.24B. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CTSH currently screens at market cap $25.17B and trailing P/E 11.5. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CTSH and EBS stock pages for the full models.
Not investment advice.